StemCells Inc.
3155 Porter Drive
Palo Alto,
CA 94304-1213
United States - Map
Phone: 650-475-3100
Fax: 650-475-3101
Web Site: http://www.stemcellsinc.com
| StemCells, Inc., a clinical-stage biotechnology company, focuses on the research, development, and commercialization of products derived from stem cell technologies. It focuses on developing cell-based therapeutics to treat diseases of the central nervous system and liver. The companys lead product candidate, HuCNS-SC cells are purified human neural stem cells, which can be expanded and banked until they are delivered as patient doses. StemCells has completed Phase I clinical trial of HuCNS-SC cells as a potential treatment for neuronal ceroid lipofuscinosis, a rare and fatal neurodegenerative disease that affects infants and young children. The company has also received approval from the U.S. Food and Drug Administration to initiate Phase I clinical trial of the HuCNS-SC cells as a potential treatment for Pelizaeus-Merzbacher Disease, a rare and fatal brain disorder that primarily affects young children. In addition, StemCells, through its wholly owned subsidiary, Stem Cell Sciences UK Ltd, is also pursuing applications of its cell-based technologies to develop research and drug screening tools, such as cell-based assays, and media and reagent tools. StemCells has exclusive rights to approximately 55 issued or allowed U.S. patents and approximately 200 granted or allowed non-U.S. patents. The company was founded in 1988 and is based in Palo Alto, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Martin M. McGlynn , 63
Chief Exec. Officer, Pres, Director, Member of Strategic Transactions Committee, Chief Exec. Officer of StemCells California Inc and Pres of StemCells California Inc |
$
462.00K |
$
376.00K | Mr. Rodney K. B. Young , 46
Chief Financial Officer and VP of Fin. & Admin. |
N/A
| N/A | Dr. Ann Tsukamoto Ph.D., 56
Chief Operating Officer and Exec. VP of R&D |
N/A
| N/A | Mr. Kenneth B. Stratton JD, 40
Sec. and Gen. Counsel |
$
291.00K | N/A | Dr. Stewart Craig Ph.D., 47
Sr. VP of Devel. & Operations |
$
84.00K | N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.23% Nasdaq 
Profile
